Comprehensive Physiology Wiley Online Library

Euthyroid Sick Syndrome

Full Article on Wiley Online Library



ABSTRACT

In this review, we discuss the characteristics, pathophysiology, and therapeutic implications of the euthyroid sick syndrome. Multiple mechanisms have been identified to contribute to the development of euthyroid sick syndrome, including alterations in the iodothyronine deiodinases, thyroid‐stimulating hormone secretion, thyroid hormone binding to plasma protein, transport of thyroid hormone in peripheral tissues, and thyroid hormone receptor activity. The euthyroid sick syndrome appears to be a complex mix of physiologic adaptation and pathologic response to acute illness. The underlying cause for these alterations has not yet been elucidated. Treatment of the euthyroid sick syndrome with thyroid hormone to restore normal serum thyroid hormone levels in an effort to improve disease prognosis and outcomes continues to be a focus of many clinical studies, although currently available data do not provide evidence of a clear benefit of treatment. © 2016 American Physiological Society. Compr Physiol 6:1071‐1080, 2016.

References
 1. Acker CG , Flick R , Shapiro R , Scantlebury VP , Jordan ML , Vivas C , Greenberg A , Johnson JP . Thyroid hormone in the treatment of post‐transplant acute tubular necrosis (ATN). Am J Transplant 2: 57‐61, 2002.
 2. Acker CG , Singh AR , Flick RP , Bernardini J , Greenberg A , Johnson JP . A trial of thyroxine in acute renal failure. Kidney Int 57: 293‐298, 2000.
 3. Afandi B , Schussler GC , Arafeh AH , Boutros A , Yap MG , Finkelstein A . Selective consumption of thyroxine‐binding globulin during cardiac bypass surgery. Metabolism 49: 270‐274, 2000.
 4.De Alfieri W , Nisticò F , Borgogni T , Riello F , Cellai F , Mori C , Nante N , Di Bari M . Thyroid hormones as predictors of short‐ and long‐term mortality in very old hospitalized patients. J Gerontol A Biol Sci Med Sci 68: 1122‐1128, 2013.
 5. Amato M , Guggisberg C , Schneider H . Postnatal triiodothyronine replacement and respiratory distress syndrome of the preterm infant. Horm Res 32: 213‐217, 1989.
 6. Becker RA , Vaughan GM , Ziegler MG , Seraile LG , Goldfarb IW , Mansour EH , McManus WF , Pruitt BA , Mason AD . Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 10: 870‐875, 1982.
 7. Bennett‐Guerrero E , Jimenez JL , White WD , D'Amico EB , Baldwin BI , Schwinn DA . Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double‐blind, placebo‐controlled trial. Duke T3 study group. JAMA 275: 687‐692, 1996.
 8. Benvenga S . Thyroid hormone transport proteins and the physiology of hormone binding. In: Braverman LE , Cooper DS , editors. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams & Wilkins, 2013, pp. 93‐103.
 9. Van den Berghe G . Non‐thyroidal illness in the ICU: A syndrome with different faces. Thyroid 24: 1456‐1465, 2014.
 10. Van den Berghe G , Wouters P , Weekers F , Mohan S , Baxter RC , Veldhuis JD , Bowers CY , Bouillon R . Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone‐releasing peptide and thyrotropin‐releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 84: 1311‐1323, 1999.
 11. Van den Berghe G , de Zegher F , Lauwers P . Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 41: 731‐737, 1994.
 12. Bettendorf M , Schmidt KG , Grulich‐Henn J , Ulmer HE , Heinrich UE . Tri‐iodothyronine treatment in children after cardiac surgery: A double‐blind, randomised, placebo‐controlled study. Lancet 356: 529‐534, 2000.
 13. Bianco AC , Kim BW . Intracellular pathways of iodothyronine metabolism/ implications of deiodination for thyorid hormone action. In: Braverman LE , Cooper DS , editors. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams & Wilkins, 2013, pp. 103‐126.
 14. Boelen A , Kwakkel J , Fliers E . Beyond low plasma T3: Local thyroid hormone metabolism during inflammation and infection. Endocr Rev 32: 670‐693, 2011.
 15. Boelen A , Wiersinga WM , Fliers E . Fasting‐induced changes in the hypothalamus‐pituitary‐thyroid axis. Thyroid 18: 123‐129, 2008.
 16. Boonen E , Van den Berghe G . Endocrine responses to critical illness: Novel insights and therapeutic implications. J Clin Endocrinol Metab 99: 1569‐1582, 2014.
 17. Brent GA , Hershman JM . Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 63: 1‐8, 1986.
 18. Byerley LO , Heber D . Metabolic effects of triiodothyronine replacement during fasting in obese subjects. J Clin Endocrinol Metab 81: 968‐976, 1996.
 19. Castro I , Quisenberry L , Calvo R‐M , Obregon M‐J , Lado‐Abeal J . Septic shock non‐thyroidal illness syndrome causes hypothyroidism and conditions for reduced sensitivity to thyroid hormone. J Mol Endocrinol 50: 255‐266, 2013.
 20. Chopra IJ . Simultaneous measurement of free thyroxine and free 3,5,3'‐triiodothyronine in undiluted serum by direct equilibrium dialysis/radioimmunoassay: Evidence that free triiodothyronine and free thyroxine are normal in many patients with the low triiodothyronine syndrome. Thyroid 8: 249‐257, 1998.
 21. Chopra IJ , Santini F , Wu SY , Hurd RE . The role of sulfation and de‐sulfation in thyroid hormone metabolism. In: Wu, SY and Visser, TJ, editors. Thyroid Hormone Metabolism: Molecular Biology and Alternate Pathways. Boca Raton: CRC Press, 1994, pp. 119‐138.
 22. Chowdhry P , Scanlon JW , Auerbach R , Abbassi V . Results of controlled double‐blind study of thyroid replacement in very low‐birth‐weight premature infants with hypothyroxinemia. Pediatrics 73: 301‐305, 1984.
 23. Chowdhury D , Ojamaa K , Parnell VA , McMahon C , Sison CP , Klein I . A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. J Thorac Cardiovasc Surg 122: 1023‐1025, 2001.
 24. Chuang C‐P , Jong Y‐S , Wu C‐Y , Lo H‐M . Impact of triiodothyronine and N‐terminal pro‐B‐type natriuretic peptide on the long‐term survival of critically ill patients with acute heart failure. Am J Cardiol 113: 845‐850, 2014.
 25. Cooper DKC , Novitzky D , Wicomb WN , Basker M , Rosendale JD , Myron Kauffman H . A review of studies relating to thyroid hormone therapy in brain‐dead organ donors. Front Biosci Landmark Ed 14: 3750‐3770, 2009.
 26. Coppola A , Liu Z‐W , Andrews ZB , Paradis E , Roy M‐C , Friedman JM , Ricquier D , Richard D , Horvath TL , Gao X‐B , Diano S . A central thermogenic‐like mechanism in feeding regulation: An interplay between arcuate nucleus T3 and UCP2. Cell Metab 5: 21‐33, 2007.
 27. Corsonello A , Buemi M , Artemisia A , Giorgianni G , Mauro VN , Corica F . Plasma leptin concentrations in relation to sick euthyroid syndrome in elderly patients with nonthyroidal illnesses. Gerontology 46: 64‐70, 2000.
 28. D'Aloia A , Vizzardi E , Bugatti S , Rovetta R , Bonadei I , Del Magro F , Curnis A , Dei Cas L . Effect of short‐term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low‐triiodothyronine syndrome. J Investig Med 60: 907‐910, 2012.
 29. DeGroot LJ. “Non‐thyroidal illness syndrome” is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge. J Endocrinol Invest 26: 1163‐1170, 2003.
 30. Van der Deure WM , Peeters RP , Visser TJ . Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters. J Mol Endocrinol 44: 1‐11, 2010.
 31. Dikdan GS , Mora‐Esteves C , Koneru B . Review of randomized clinical trials of donor management and organ preservation in deceased donors: Opportunities and issues. Transplantation 94: 425‐441, 2012.
 32. Drechsler C , Schneider A , Gutjahr‐Lengsfeld L , Kroiss M , Carrero JJ , Krane V , Allolio B , Wanner C , Fassnacht M . Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. Am J Kidney Dis 63: 988‐996, 2014.
 33. Economidou F , Douka E , Tzanela M , Nanas S , Kotanidou A . Thyroid function during critical illness. Horm Athens Greece 10: 117‐124, 2011.
 34. Eshraghian A , Taghavi SA . Systematic review: Endocrine abnormalities in patients with liver cirrhosis. Arch Iran Med 17: 713‐721, 2014.
 35. Farwell AP . Thyroid hormone therapy is not indicated in the majority of patients with the sick euthyroid syndrome. Endocr Pract Endocrinol 14: 1180‐1187, 2008.
 36. Farwell AP . Nonthyroidal illness syndrome. Curr Opin Endocrinol Diabetes Obes 20: 478‐484, 2013.
 37. Feingold K , Kim MS , Shigenaga J , Moser A , Grunfeld C . Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute‐phase response. Am J Physiol Endocrinol Metab 286: E201‐E207, 2004.
 38. Fekete C , Gereben B , Doleschall M , Harney JW , Dora JM , Bianco AC , Sarkar S , Liposits Z , Rand W , Emerson C , Kacskovics I , Larsen PR , Lechan RM . Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: Implications for the nonthyroidal illness syndrome. Endocrinology 145: 1649‐1655, 2004.
 39. Fekete C , Lechan RM . Negative feedback regulation of hypophysiotropic thyrotropin‐releasing hormone (TRH) synthesizing neurons: Role of neuronal afferents and type 2 deiodinase. Front Neuroendocrinol 28: 97‐114, 2007.
 40. Frey A , Kroiss M , Berliner D , Seifert M , Allolio B , Güder G , Ertl G , Angermann CE , Störk S , Fassnacht M . Prognostic impact of subclinical thyroid dysfunction in heart failure. Int J Cardiol 168: 300‐305, 2013.
 41. Galton VA , Schneider MJ , Clark AS , St Germain DL . Life without thyroxine to 3,5,3'‐triiodothyronine conversion: Studies in mice devoid of the 5'‐deiodinases. Endocrinology 150: 2957‐2963, 2009.
 42. Gangemi EN , Garino F , Berchialla P , Martinese M , Arecco F , Orlandi F , Stella M . Low triiodothyronine serum levels as a predictor of poor prognosis in burn patients. Burns J Int Soc Burn Inj 34: 817‐824, 2008.
 43. Gardner DF , Kaplan MM , Stanley CA , Utiger RD . Effect of tri‐iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 300: 579‐584, 1979.
 44. Gerdes AM . Restoration of thyroid hormone balance: A game changer in the treatment of heart failure? Am J Physiol Heart Circ Physiol 308: H1‐H10, 2015.
 45. Goarin JP , Cohen S , Riou B , Jacquens Y , Guesde R , Le Bret F , Aurengo A , Coriat P . The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 83: 41‐47, 1996.
 46. Haddady S , Farwell AP . Non‐thyroidal illness and the management of thyroid disorders in the Intensive Care Unit. In: Irwin RS , Rippe JM , editors. Intensive Care Medicine. Philadelphia, PA: Lippincott Williams & Wilkins, 2011, pp. 1182‐1194.
 47. Hamblin PS , Dyer SA , Mohr VS , Le Grand BA , Lim CF , Tuxen DV , Topliss DJ , Stockigt JR . Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab 62: 717‐722, 1986.
 48. Hamilton MA , Stevenson LW , Fonarow GC , Steimle A , Goldhaber JI , Child JS , Chopra IJ , Moriguchi JD , Hage A . Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol 81: 443‐447, 1998.
 49. Han G , Ren J , Liu S , Gu G , Ren H , Yan D , Chen J , Wang G , Zhou B , Wu X , Yuan Y , Li J . Nonthyroidal illness syndrome in enterocutaneous fistulas. Am J Surg 206: 386‐392, 2013.
 50. Heemstra KA , Soeters MR , Fliers E , Serlie MJ , Burggraaf J , van Doorn MB , van der Klaauw AA , Romijn JA , Smit JW , Corssmit EP , Visser TJ . Type 2 iodothyronine deiodinase in skeletal muscle: Effects of hypothyroidism and fasting. J Clin Endocrinol Metab 94: 2144‐2150, 2009.
 51. Hennemann G , Krenning EP . The kinetics of thyroid hormone transporters and their role in non‐thyroidal illness and starvation. Best Pract Res Clin Endocrinol Metab 21: 323‐338, 2007.
 52. Heuer H , Maier MK , Iden S , Mittag J , Friesema ECH , Visser TJ , Bauer K . The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone‐sensitive neuron populations. Endocrinology 146: 1701‐1706, 2005.
 53. Horáček J , Dusilová Sulková S , Kubišová M , Safránek R , Malířová E , Kalousová M , Svilias I , Malý J , Sobotka L , Zák P . Thyroid hormone abnormalities in hemodialyzed patients: Low triiodothyronine as well as high reverse triiodothyronine are associated with increased mortality. Physiol Res Acad Sci Bohemoslov 61: 495‐501, 2012.
 54. Hsieh C‐J , Wang P‐W , Wang S‐T , Liu R‐T , Tung S‐C , Chien W‐Y , Lu Y‐C , Chen J‐F , Chen C‐H , Kuo M‐C . Serum leptin concentrations of patients with sequential thyroid function changes. Clin Endocrinol (Oxf) 57: 29‐34, 2002.
 55. Huang SA , Bianco AC . Reawakened interest in type III iodothyronine deiodinase in critical illness and injury. Nat Clin Pract Endocrinol Metab 4: 148‐155, 2008.
 56. Iervasi G , Pingitore A , Landi P , Raciti M , Ripoli A , Scarlattini M , L'Abbate A , Donato L . Low‐T3 syndrome: A strong prognostic predictor of death in patients with heart disease. Circulation 107: 708‐713, 2003.
 57. Iglesias P , Díez JJ . Thyroid dysfunction and kidney disease. Eur J Endocrinol Eur Fed Endocr Soc 160: 503‐515, 2009.
 58. Jeevanandam V . Triiodothyronine: Spectrum of use in heart transplantation. Thyroid 7: 139‐145, 1997.
 59. Jeevanandam V , Todd B , Regillo T , Hellman S , Eldridge C , McClurken J . Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 13: 681‐687; discussion 685‐687, 1994.
 60. Kaptein EM , Sanchez A , Beale E , Chan LS . Clinical review: Thyroid hormone therapy for postoperative nonthyroidal illnesses: A systematic review and synthesis. J Clin Endocrinol Metab 95: 4526‐4534, 2010.
 61. Kaptein EM , Weiner JM , Robinson WJ , Wheeler WS , Nicoloff JT . Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses. Clin Endocrinol (Oxf) 16: 565‐574, 1982.
 62. Klemperer JD , Klein I , Gomez M , Helm RE , Ojamaa K , Thomas SJ , Isom OW , Krieger K . Thyroid hormone treatment after coronary‐artery bypass surgery. N Engl J Med 333: 1522‐1527, 1995.
 63. Koo HM , Kim CH , Doh FM , Lee MJ , Kim EJ , Han JH , Han JS , Oh HJ , Han SH , Yoo T‐H , Kang S‐W . The impact of low triiodothyronine levels on mortality is mediated by malnutrition and cardiac dysfunction in incident hemodialysis patients. Eur J Endocrinol Eur Fed Endocr Soc 169: 409‐419, 2013.
 64. Koppeschaar HP , Meinders AE , Schwarz F . Metabolic responses in grossly obese subjects treated with a very‐low‐calorie diet with and without triiodothyronine treatment. Int J Obes 7: 133‐141, 1983.
 65. Langouche L , Vander Perre S , Marques M , Boelen A , Wouters PJ , Casaer MP , Van den Berghe G . Impact of early nutrient restriction during critical illness on the nonthyroidal illness syndrome and its relation with outcome: A randomized, controlled clinical study. J Clin Endocrinol Metab 98: 1006‐1013, 2013.
 66. Lechan RM , Fekete C . Role of thyroid hormone deiodination in the hypothalamus. Thyroid 15: 883‐897, 2005.
 67. Lim CF , Docter R , Visser TJ , Krenning EP , Bernard B , van Toor H , de Jong M , Hennemann G . Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: Effects of bilirubin and nonesterified fatty acids. J Clin Endocrinol Metab 76: 1165‐1172, 1993.
 68. Maldonado LS , Murata GH , Hershman JM , Braunstein GD . Do thyroid function tests independently predict survival in the critically ill? Thyroid 2: 119‐123, 1992.
 69. Marks SD . Nonthyroidal illness syndrome in children. Endocrine 36: 355‐367, 2009.
 70. Mebis L , Debaveye Y , Ellger B , Derde S , Ververs E‐J , Langouche L , Darras VM , Fliers E , Visser TJ , Van den Berghe G . Changes in the central component of the hypothalamus‐pituitary‐thyroid axis in a rabbit model of prolonged critical illness. Crit Care 13: R147, 2009.
 71. Mebis L , Langouche L , Visser TJ , Van den Berghe G . The type II iodothyronine deiodinase is up‐regulated in skeletal muscle during prolonged critical illness. J Clin Endocrinol Metab 92: 3330‐3333, 2007.
 72. Meuwese CL , Carrero JJ , Cabezas‐Rodríguez I , Heimburger O , Barany P , Lindholm B , Qureshi AR , Ripsweden J , Dekker FW , Stenvinkel P . Nonthyroidal illness: A risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis? J Intern Med 274: 584‐593, 2013.
 73. Meuwese CL , Dekkers OM , Stenvinkel P , Dekker FW , Carrero JJ . Nonthyroidal illness and the cardiorenal syndrome. Nat Rev Nephrol 9: 599‐609, 2013.
 74. Moruzzi P , Doria E , Agostoni PG . Medium‐term effectiveness of l‐thyroxine treatment in idiopathic dilated cardiomyopathy. Am J Med 101: 461‐467, 1996.
 75. Mullur R , Liu Y‐Y , Brent GA . Thyroid hormone regulation of metabolism. Physiol Rev 94: 355‐382, 2014.
 76. Nelson JC , Weiss RM . The effect of serum dilution on free thyroxine (T4) concentration in the low T4 syndrome of nonthyroidal illness. J Clin Endocrinol Metab 61: 239‐246, 1985.
 77. Novitzky D , Cooper DK , Barton CI , Greer A , Chaffin J , Grim J , Zuhdi N . Triiodothyronine as an inotropic agent after open heart surgery. J Thorac Cardiovasc Surg 98: 972‐977; discussion 977‐978, 1989.
 78. Novitzky D , Cooper DK , Swanepoel A . Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: An initial experience in patients undergoing open heart surgery. Eur J Cardio‐Thorac Surg 3: 140‐145, 1989.
 79. Novitzky D , Cooper DKC . Thyroid hormone and the stunned myocardium. J Endocrinol 223: R1‐R8, 2014.
 80. Novitzky D , Cooper DKC , Rosendale JD , Kauffman HM . Hormonal therapy of the brain‐dead organ donor: Experimental and clinical studies. Transplantation 82: 1396‐1401, 2006.
 81. Novitzky D . Novel actions of thyroid hormone: The role of triiodothyronine in cardiac transplantation. Thyroid 6: 531‐536, 1996.
 82. Novitzky D , Mi Z , Sun Q , Collins JF , Cooper DKC . Thyroid hormone therapy in the management of 63,593 brain‐dead organ donors: A retrospective analysis. Transplantation 98: 1119‐1127, 2014.
 83. Obregon MJ , Calvo RM , Del Rey FE , de Escobar GM . Ontogenesis of thyroid function and interactions with maternal function. Endocr Dev 10: 86‐98, 2007.
 84. Oetting A , Yen PM . New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 21: 193‐208, 2007.
 85. Osborn DA . Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. Cochrane Database Syst Rev 2000(2): CD001070.
 86. Pappa TA , Vagenakis AG , Alevizaki M . The nonthyroidal illness syndrome in the non‐critically ill patient. Eur J Clin Invest 41: 212‐220, 2011.
 87. Peeters RP . Non thyroidal illness: To treat or not to treat? Ann Endocrinol 68: 224‐228, 2007.
 88. Peeters RP , van der Geyten S , Wouters PJ , Darras VM , van Toor H , Kaptein E , Visser TJ , Van den Berghe G . Tissue thyroid hormone levels in critical illness. J Clin Endocrinol Metab 90: 6498‐6507, 2005.
 89. Peeters RP , Wouters PJ , van Toor H , Kaptein E , Visser TJ , Van den Berghe G . Serum 3,3',5'‐triiodothyronine (rT3) and 3,5,3'‐triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 90: 4559‐4565, 2005.
 90. Pérez‐Guisado J , de Haro‐Padilla JM , Rioja LF , Derosier LC , de la Torre JI . The potential association of later initiation of oral/enteral nutrition on euthyroid sick syndrome in burn patients. Int J Endocrinol 2013: 707360, 2013.
 91. Pingitore A , Galli E , Barison A , Iervasi A , Scarlattini M , Nucci D , L'abbate A , Mariotti R , Iervasi G . Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low‐T3 syndrome: A randomized, placebo‐controlled study. J Clin Endocrinol Metab 93: 1351‐1358, 2008.
 92. Pingitore A , Landi P , Taddei MC , Ripoli A , L'Abbate A , Iervasi G . Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 118: 132‐136, 2005.
 93. Plikat K , Langgartner J , Buettner R , Bollheimer LC , Woenckhaus U , Schölmerich J , Wrede CE . Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism 56: 239‐244, 2007.
 94. Rovet J , Daneman D . Congenital hypothyroidism: A review of current diagnostic and treatment practices in relation to neuropsychologic outcome. Paediatr Drugs 5: 141‐149, 2003.
 95. Selvaraj N , Bobby Z , Sridhar MG . Is euthyroid sick syndrome a defensive mechanism against oxidative stress? Med Hypotheses 71: 404‐405, 2008.
 96. Slag MF , Morley JE , Elson MK , Crowson TW , Nuttall FQ , Shafer RB . Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 245: 43‐45, 1981.
 97. Spencer C , Eigen A , Shen D , Duda M , Qualls S , Weiss S , Nicoloff J . Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 33: 1391‐1396, 1987.
 98. Spencer CA . Clinical utility and cost‐effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clin Proc 63: 1214‐1222, 1988.
 99. St Germain DL , Galton VA , Hernandez A . Minireview: Defining the roles of the iodothyronine deiodinases: Current concepts and challenges. Endocrinology 150: 1097‐1107, 2009.
 100. Stockigt JR , Lim C‐F . Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract Res Clin Endocrinol Metab 23: 753‐767, 2009.
 101. Sugiyama D , Kusuhara H , Taniguchi H , Ishikawa S , Nozaki Y , Aburatani H , Sugiyama Y . Functional characterization of rat brain‐specific organic anion transporter (Oatp14) at the blood‐brain barrier high affinity transporter for thyroxine. J Biol Chem 278: 43489‐43495, 2003.
 102. Teiger E , Menasché P , Mansier P , Chevalier B , Lajeunie E , Bloch G , Piwnica A . Triiodothyronine therapy in open‐heart surgery: From hope to disappointment. Eur Heart J 14: 629‐633, 1993.
 103. Vidart J , Magagnin Wajner S , Sarmento Leite R , Manica A , Schaan BD , Reed Larsen P , Maia AL . N‐Acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: A randomized clinical trial. J Clin Endocrinol Metab 99: 4537‐4545, 2014.
 104. Visser WE , Friesema ECH , Visser TJ . Minireview: Thyroid hormone transporters: The knowns and the unknowns. Mol Endocrinol 25: 1‐14, 2011.
 105. Wang F , Pan W , Wang H , Wang S , Pan S , Ge J . Relationship between thyroid function and ICU mortality: A prospective observation study. Crit Care 16: R11, 2012.
 106. Warner MH , Beckett GJ . Mechanisms behind the non‐thyroidal illness syndrome: An update. J Endocrinol 205: 1‐13, 2010.
 107. Van Wassenaer AG , Kok JH , de Vijlder JJ , Briët JM , Smit BJ , Tamminga P , van Baar A , Dekker FW , Vulsma T . Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 336: 21‐26, 1997.
 108. Williams GR , Franklyn JA , Neuberger JM , Sheppard MC . Thyroid hormone receptor expression in the “sick euthyroid” syndrome. Lancet 2: 1477‐1481, 1989.
 109. Zaroff JG , Rosengard BR , Armstrong WF , Babcock WD , D'Alessandro A , Dec GW , Edwards NM , Higgins RS , Jeevanandum V , Kauffman M , Kirklin JK , Large SR , Marelli D , Peterson TS , Ring WS , Robbins RC , Russell SD , Taylor DO , Van Bakel A , Wallwork J , Young JB . Consensus conference report: Maximizing use of organs recovered from the cadaver donor: Cardiac recommendations, March 28‐29, 2001, Crystal City, VA. Circulation 106: 836‐841, 2002.

Contact Editor

Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite

Sun Lee, Alan P. Farwell. Euthyroid Sick Syndrome. Compr Physiol 2016, 6: 1071-1080. doi: 10.1002/cphy.c150017